logo

For the Inventor, By the Inventor

Norcross, GA, United States of America

Galectin Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 18



Trademarks = 3

Forward Citations = 73

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Eliezer Zomer (16 out of 38 patents)

silverMedal Anatole A Klyosov (15 out of 28 patents)

bronzeMedal Peter G Traber (13 out of 17 patents)

4.  Elena Chekhova (7 out of 7 patents)

5.  David C Platt (5 out of 64 patents)

6.  William L Redmond (1 out of 2 patents)

7.  Stefanie N Linch (1 out of 2 patents)


18 patents:

1. 11413303 - Methods for treatment of arthritis (2022-08-16),
2. 10799525 - Composition of novel carbohydrate drug for treatment of human diseases (2020-10-13),
3. 10744154 - Galactose-pronged polysaccharides in a formulation for antifibrotic therapies (2020-08-18),
4. 10420793 - Composition of novel carbohydrate drug for treatment of human diseases (2019-09-24),
5. 10398778 - Method for enhancing specific immunotherapies in cancer treatment (2019-09-03),
6. 9974802 - Composition of novel carbohydrate drug for treatment of human diseases (2018-05-22),
7. 9968631 - Method for treatment of pulmonary fibrosis (2018-05-15),
8. 9763974 - Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase (2017-09-19),
9. 9649327 - Composition of novel carbohydrate drug for treatment of human diseases (2017-05-16),
10. 9339515 - Method for treatment of pulmonary fibrosis (2016-05-17),
11. 9200090 - Galactose-pronged polysaccharides in a formulation for antifibrotic therapies (2015-12-01),
12. 8962824 - Composition of novel carbohydrate drug for treatment of human diseases (2015-02-24),
13. 8871925 - Compositions of novel carbohydrate drug for treatment of human diseases (2014-10-28),
14. 8828971 - Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders (2014-09-09),
15. 8722645 - Galactose-pronged polysaccharides in a formulation for antifibrotic therapies (2014-05-13),
Company Overview
Galectin Therapeutics, Inc. is a biopharmaceutical company based in Norcross, Georgia, focused on developing innovative therapies for fibrotic diseases and cancer. The company specializes in the research and development of galectin-based therapeutics, which target specific carbohydrate-binding proteins involved in various disease processes. By leveraging its proprietary technology, Galectin Therapeutics aims to address unmet medical needs and improve patient outcomes through advanced treatment options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#31 in Norcross, GA

#345 in Georgia

#17,980 in US

#34,263 in the World

Norcross, GA (US)
Norcross, GA, United States of America

Galectin Therapeutics, Inc.

Forward Citations = 73

7 inventors:

goldMedal Eliezer Zomer (16 out of 38 patents)

silverMedal Anatole A Klyosov (15 out of 28 patents)

bronzeMedal Peter G Traber (13 out of 17 patents)

4.  Elena Chekhova (7 out of 7 patents)

5.  David C Platt (5 out of 64 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galectin Therapeutics, Inc.. Retrieved from https://idiyas.com/company/galectin-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…